MedPath

Yashtimadhu-Siddha Ghrita Akshitarpana in Dry Eye

Phase 2
Not yet recruiting
Conditions
Diseases of the eye and adnexa. Ayurveda Condition: SUSHKAKSHIPAKAH,
Registration Number
CTRI/2021/09/036976
Lead Sponsor
Govt Ayurvedic College and Hospital Kadamkuan Patna
Brief Summary

In Sushruta Samhita, Shushkashipaka is described with the clinical features like burning sensation, irritation, strain, redness in the eyes along with blurring of vision and headache which are similar to that of Dry eye. It is a multifactorial disorder due to inflammation of ocular surface and lacrimal gland, neurotrophic deficiency and meibomian gland dysfunction. Due to wide spectrum of disease and much prevalence in the society, this disease is selected for the comparative study using Yashtimadhu siddha ghrita and go-ghrita for Akshitarpana.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patient presenting with the classical features of shushkakshipaka as well as symptoms suggestive of dry eye syndrome.

Exclusion Criteria
  • Age less than 25 years and more than 60 years, pregnancy, patient having symptoms of perforated corneal ulcer, uveitis, glaucoma, acute conjunctivitis, systemic metabolic disease causing dry eye syndrome patient with impaired eyelid function.
  • patient with occular surgery prior to three month of study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in symptoms of Shushkakshipaka60 days
Secondary Outcome Measures
NameTimeMethod
Improvement insymptoms of Shushkakshipaka60 days

Trial Locations

Locations (1)

Government Ayurvedic College and Hospital, Patna

🇮🇳

Patna, BIHAR, India

Government Ayurvedic College and Hospital, Patna
🇮🇳Patna, BIHAR, India
Dr Dharmendra Prasad
Principal investigator
8298510230
prasaddharmendra19@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.